An FDA committee is recommending the addition of several peptides to the 503A bulk drug substances list.
The FDA’s Pharmacy Compounding Advisory Committee, which has faced scrutiny for having several members with conflicts of interest, met July 23 and 24 to discuss peptides.
Owais Durrani, DO, an emergency medicine physician in Houston, previously wrote for Healio that “some of the most transformative drugs in modern medicine are peptides,” including insulin and semaglutide. While “the science of peptides is real, serious and worth pursuing,” Durrani wrote, the current system is messy: “a